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Objectives: Despite increasing prevalence of venous thromboembolism (VTE) in 
China, real-world use of anticoagulants in clinical practice is not well understood. 
This study aims to assess treatment pattern and anticoagulant monitoring among 
hospitalized VTE patients in China. MethOds: Hospitalizations with a diagnosis of 
VTE (including deep vein thrombosis (DVT) or pulmonary embolism (PE)) between 
January 1st, 2010 and June 30th, 2013 were identified from a large electronic medical 
record database containing 100% inpatient records from two tertiary hospitals in two 
major cities. Analyses were performed to describe anticoagulant treatment among 
all VTE-related hospitalizations and international normalized ratio (INR) monitoring 
among hospitalizations where warfarin was used. Multivariate regressions were per-
formed to assess factors associated with oral anticoagulant use, including type of VTE, 
patient demographics, comorbidities, insurance status, VTE diagnosis type, admission 
condition, ordering department, and surgical procedure. Results: Among a total of 
1,047 VTE-related hospitalizations, mean age at hospitalization was 62.4 years, 54.1% 
of hospitalizations occurred to men, and 77.1% were DVT-related hospitalizations. 
About 46.3% hospitalizations used heparin only, 35.0% used warfarin (with or without 
heparin), 0.8% used rivaroxaban, and 18.0% did not use any anticoagulant. Among 
hospitalizations where warfarin was used, 90.8% received at least one INR test before 
discharge; among hospitalizations with INR results available, 30.0% had the last INR 
during hospitalization within target therapeutic range (2 to 3). Diagnosis of PE (vs. 
DVT), female, cardiovascular as ordering department, having surgical procedures, 
comorbidity of chronic pulmonary disorder, and VTE as primary diagnosis were sig-
nificantly associated with higher oral anticoagulant use (all P < 0.05). cOnclusiOns: 
In China, use of innovative oral anticoagulants is limited among hospitalized VTE 
patients. Under-monitoring and suboptimal care may be an issue for hospitalized 
patients treated with warfarin. These findings reveal gaps in clinical practice and 
unmet needs among hospitalized patients with VTE in China.
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Objectives: Study potentially inappropriate drug use of geriatrics and medica-
tions, which were used for the 65 years and older in-patients, with chronic ischemic 
heart disease, of some tertiary level hospitals. MethOds: The retrospective study 
involved 65 and over aged 438 in-patients randomly collected records, who were 
treated at I, II and III state hospitals, in 2010-2012, with Chronic ischemic heart 
disease/CIHD/. Results: The 2nd and 3rd hospitals commonly use aspirin as an 
anti-platelet agent whereas the 1st state hospital uses dipyridamole, clopidogrel 
with aspirin. To improve coronary circulation and decrease the heart pain the 2nd 
(55%) and 3rd (64%) state hospitals use nitrates, but the 1st state hospital had no 
evidence of using this group medication for the patients with CIHD. 1st state hos-
pital regularly uses beta-blockers (61%) for decreasing cardiac oxygen demand and 
improves heart microcirculation. The angiotensin converting enzyme and diuretic 
group medications were more used in 1st and 3rd state hospitals. 1365 medications 
were used (n= 149) and 331 (24.2%) of them was potentially inappropriate medica-
tions and related to the 1st group of Beers criteria. In the 2nd state hospital:1007 
medications: 204 (20%) - potentially inappropriate medications and 194 (19%)- 1st 
group drugs of Beers criteria; the 3rd state hospital - 1162 medications:151 (13%) – 
potentially inappropriate medications. cOnclusiOns: The 30.1%-48.5% of the total 
medications, prescribed for CIHD, in the tertiary hospitals, were agreed with CIHD 
therapeutic and diagnosis guidelines. 50% of the total medications used for CIHD, 
were accompanied diagnoses and other drugs.
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Objectives: Lipid control is crucial in patients undergoing percutaneous coro-
nary intervention (PCI). Lipid guidelines recommend that all patients with coronary 
heart disease should have low density lipoproteins cholesterol (LDL-C) goals to 
be < 100 mg/dl with the ideal therapeutic option < 70 mg/dl. The primary objec-
tive of this research was to evaluate the success rate of lipid control during the 
six months after PCI. MethOds: We conducted a retrospective, observational 
study on all patients who underwent PCI at a large urban hospital in Shanghai, 
China from 5/2010 to 6/2011. Patients who had lipid measures at 30-day or 180-day 
follow-ups were included in the analysis. Percentages of patients that achieved 
LDL-C treatment goals of < 100 and < 70 were assessed, respectively. Statin use 
was also reported. Results: A total of 119 patients (82.4% male) were included in 
this analysis. The mean age was 64 years (range 40 to 90). Overall, 69.8% of patients 
had angina, 63.9% hypertension, 29.4% diabetes, 22.7 % previous myocardial infarc-
tion, 16.0% hyperlipidemic pancreatitis, and 9.2% chronic kidney disease. 52.9% of 
patients were active smokers or previously smoked and PCI was not the first time for 
10.9% of patients. After PCI, all but one patient at 30-day follow-up, and all patients 
at 180-day follow-up, reported use of statins. The proportion of patients meeting 
minimum LDL-C goal (< 100) decreased slightly from 69.1% at 30-day follow-up to 
67.9% at 180-day follow-up; the percentage of patients meeting ideal LDL-C goal 
(< 70) decreased substantially from 30.9% to 23.9% among all patients, and from 
43.4% to 32.1% (p< 0.05) among male aged 60 years or older. cOnclusiOns: Despite 
statin treatment, at least 30% of patients were not at the recommended LDL-C goal 
of < 100 mg/dl six months post PCI and only one quarter of these high risk patients 
were at the optimal goal of < 70 mg/dl.
the cardiology wards with unstable angina and myocardial infarction and under-
went angioplasty procedure, were randomized into control group where, standard 
care is provided and Intervention group where, Pharmaceutical care was provided 
with tailor made counseling about diseases, drugs, diet and lifestyle modifications. 
Quality of Life assessment was done with EQ 5D 5L and MacNew Questionnaires by 
interview method at 3 months, 6 months, 9 months and at 12 months. Results: 213 
participants were randomized into control group (n= 105) and intervention group 
(n= 108). Socio-demographic characteristics at baseline are similar between two 
groups. At baseline, Global Scores of MacNew questionnaire of both the groups have 
similar scores (3.03 ± 1.29 & 2.89 ±1.12). At 12 months, scores of 2.32 ±0.91 and 5.47 ± 
1.45 were observed for control and intervention group respectively. EQ utility values 
at base line were 0.46 ± 0.17 and 0.47 ± 0.16. At 12 months, utility values were 0.11 
± 0.20 and 0.68 ± 0.23 observed for control and intervention group respectively. EQ 
Visual analog scores at base line were 59.57 ± 14.51 and 61.01 ± 13.34. At 12 months, 
scores of 73.38 ± 5.19 and 85.13 ± 4.62 was observed for control and interventional 
groups respectively. Domains of the both questionnaire are evaluated and there was 
a significant change in the intervention group specifically, physical, emotional and 
social domains. Quality adjusted life years were 0.7114 and 0.8582 for control and 
intervention groups respectively. cOnclusiOns: Pharmaceutical care significantly 
improves the quality of life of the patients who underwent angioplasty procedure.
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Objectives: Obesity is reported to be underlying cause of metabolic syndrome 
and associated with hypertension and diabetes .A BMI (body mass index) of more 
than 30 places individuals in obese category. Majority of urban Indian population 
is categorized being overweight (BMI greater than 25). A sedentary lifestyle and lack 
of exercise in Indian cities causes belly fat accumulation which is reported to be a 
risk factor for metabolic diseases. MethOds: In this study, we have categorized 
middle class Indian population (test subjects > 500) residing in metropolitan Delhi 
area into different age groups (11-20, 21-30, 31-40, 41-50, 51-60 and 60 and above) 
and recorded BMI and degree of belly fat present (no excess belly fat, small, medium 
and high). Our data shows that age groups 11-20 and 21-30 show normal BMI and 
lower cases of accumulated belly fat whereas there is a significant increase (50%) 
in BMI and presence of belly fat in age group 31-40 and above. We also recorded 
presence of obesity related metabolic disorders such as diabetes and hypertension 
in the above mentioned age groups. Results: Test subjects in all age groups with 
BMI > 25 (over-weight and obese) recorded presence of related disorders (39.40% in 
over-weight and 67.34% in obese classes). Most prevalent diseases with higher BMI 
were hypertension, diabetes, and joint pain in decreasing order. cOnclusiOns: 
The sudden increase in obesity related factors is a matter of concern in the age 
group of 30 and above. We conclude that decrease in physical activity and sedentary 
lifestyle is the cause of belly fat accumulation and onset of obesity which results 
in metabolic diseases such as hypertension and diabetes. This information is most 
relevant for social awareness about obesity in middle class Indian population and 
through this study, it has been possible to alert the test subjects about risk of asso-
ciated disorders.
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Objectives: Obesity was said to be one of the important risks for mortality. 
Inconsistent findings have been reported in the association between obesity and 
quality of life. The study provides a finding in the question using a cross-sectional 
survey conducted in China. MethOds: A total of 1,281 hypertensive residents in 
China aged 35 years or older were included in the analysis. The short-form 36 (SF-36) 
was used to measure the quality of life. It consisted of physical and mental domains. 
The highest score was 100 and 0 for the lowest in each domain. Level of obesity 
was classified using body mass index (BMI), namely, lean (< 18.5), normal (18.5-24), 
overweight (24-28), obese (over 28) according to the Chinese classification. Means of 
physical and mental domains were calculated for the degree of obesity, adjusted for 
age, gender, marital status, education level, and exercise habits. Difference in quality 
of life among the levels of obesity was tested by the analysis of variance. Results: 
There were lean (n= 34), normal (n= 531), overweight (n= 521), obese (195) subjects 
with hypertension. Men occupied 53% and 37% for aged 60 years or older. Significant 
risk factors lowering the quality of life were women, elderly, low education and 
exercise. Adjusted mean (±standard error) of physical domain was 64±3.3 (lean), 
70±1.2 (normal), 71±1.2 (overweight), 71 ±1.6 (obese), where the p-value was 0.17. 
Whereas, the adjusted mean of mental domain was 69±3.3 (lean), 72±1.1 (normal), 
76±1.2 (overweight), 76±1.6 (obese), where the p-value was 0.018. cOnclusiOns: 
A significant increase in the mental component of quality of life was found accord-
ing to the level of obesity; however no trend was observed in the physical compo-
nent.
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anti-hyperlipidemia drugs, despite LDL-c levels above 160 mg/dL. Many reported 
themselves untreated for 3 years. These results revealed a potentially critical gap 
between health care checkup results and subject’s behavior to access medical treat-
ment, suggesting more effective interventions to modify behavior is required.
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Objectives: 1) Survey to evaluate the effectiveness of Drug Price Control Order 
(DPCO)2013: a health care policy devised by Government of India, and 2) To ana-
lyze the cost minimization benefits of the anti-hypertensive drugs falling under 
Drug Price Control Order (DPCO)2013 to the patients receiving palliative treat-
ment. MethOds: Three sets of structured questionnaires were designed which cap-
tured the patient’s gender, prescription trends for hypertensive patients in Mumbai, 
India. The survey through questionnaires, targeted 20 General Practioners, 75 Retail 
Pharmacies and 25 patients. Results: 1. Out of the total prescriptions received 
by Retail Pharmacies; Amlodipine accounted for 42%, Telmisartan: 27%, Atenolol: 
20% and Ramipril: 10%. The same trend was followed by the General Practioners. 
Amlodipine and Atenolol account for 63% of all prescriptions when considered 
together. These fall under Drug Price Control Order (DPCO)2013 and their selling 
price is Government capped and is therefore low. Telmisartan and Ramipril which 
do not fall under Drug Price Control Order (DPCO)2013 account for 37% when con-
sidered together. 2. Gender study of patient established the fact that more males 
(70%) are prone to hypertension than females(30%). 3. The average cost per dose of 
generics surveyed (Amlodipine, Atenolol) which fall under DPCO 2013 is 0.02USD 
(1.175INR) whereas that of generics (Telmisartan and Ramipril) which do not fall 
under DPCO 2013 is 0.1USD(6.3INR). cOnclusiOns: 1. Amlodipine and Atenolol 
which fall under Drug Price Control Order (DPCO) 2013 are majorly prescribed as 
compared to Telmisartan and Ramipril which do not fall under Drug Price Control 
Order (DPCO)2013. 2. The drugs which fall under DPCO 2013 are 5 times less expen-
sive than those that do not fall under DPCO 2013. Thus, the initiative taken by 
Government of India by devising this policy has made it economically viable for 
patients with palliative hypertension to meet their daily requirement of drugs.
mental health – Clinical outcomes studies
Pmh1
effiCaCy anD safety of fiVe new antiDePression Drugs a network 
meta analysis
Ren J., Wei L.
China Pharmaceutical University, Beijing, China
Objectives: To estimate the effectiveness and adverse effect rate of five anti-
depression drugs: fluoxetine, venlafaxine, maprotiline, mirtazapine and bupro-
pion ; and to systematically review those common used new antidepression 
drugs’efficacy and safety in China. MethOds: we retrieve clinical research paper 
through Chinese Journal Full Text Database (1994-2014.2), Chinese Biomedical Literature 
Database (1978-2014.2), Chinese Technology Journal Full-text Database(1989-2014.2), 
Wanfang Data of Medical Information Mirror System (1997-2014.2), Digital Journal Full 
Text Database (1997-2014.2), PubMed (1966-2014.2), Cochrane Library (2014), EMBASE 
(1974-2014.2), ISI database(1974-2014.2). We screen these papers according to the 
inclusion and exclusion criteria and assess the quality of these included researches 
. Network Meta analysis method is used to combine the RCT results . WinBUGS 
and R software are used as instrument for statistical analysis to systematically 
assess OR values and quality rank of these five drugs. Results: 89 clinical tri-
als, 7007 patients with depression, 180 arms are totally included. Network Meta-
analysis showes that fluoxetine improves effectiveness more obviously than 
venlafaxine and mirtazapine. ORvenlafaxine-fluoxetine = 0.6741[95%CI:0.5313, 0.8307], 
ORfluoxetine - mirtazapine = 1.5887 [95%CI:1.2369, 2.0220], P< 0.05. In terms of adverse 
effects, maprotiline leads to the least adverse effects rate. ORbupropion-maprotiline 
= 8.6945[95%CI:2.1496,26.4462], ORmaprotiline-venlafaxine= 0.2086 [95%CI: 0.0627,0.4958], 
ORmaprotiline-fluoxetine = 0.2109[95%CI:0.0607, 0.5422], ORmaprotiline - mirtazapine = 0.2521 
[95%CI:0.0773, 0.6173], P< 0.05. Based on bayesian theory, network meta-analysis 
also ranks these five interventions. Results show that fluoxetine, bupropion and 
maprotiline have better effectiveness; but maprotiline, fluoxetine, mirtazapine have 
less adverse effects rate. cOnclusiOns: Fluoxetine, as a new antidepressant drug, 
has higher clinical efficiency and lower adverse effects rate. Although maprotiline 
has a high grade of recommendation, we have few researches integrated into the 
model, further prospective studies are needed for strong evidence to support analo-
gous research.
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Objectives: Minimum Clinically Important Difference (MCID) can aid to assess 
the quality of improvement in functioning assessed by the Global Assessment 
Functioning (GAF). This scale, ranging between 0 and 100, subjectively rates the 
social, occupational, and psychological functioning of adults. The objective of this 
study was to generate MCID for GAF, based on a longitudinal cohort of patients with 
schizophrenia. MethOds: Two methods exist to assess MCID in scales such as GAF: 
the anchor-based approach (comparison of the change in CDSS score and Clinical 
Global Impression (CGI) within- and between-patients), and the distribution-based 
approach (comparison between the change in PRO scores and some measure of 
variability, including standard error measurement approach, standard deviation 
approach and effect size). Both methods were implemented in a longitudinal cohort 
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Objectives: This study aimed to explore the relationship between the dietary pat-
terns and blood pressure (BP) in Taiwanese females. MethOds: Cross-sectional 
study by surveying 269 Taiwanese females, 40 years of age or older, was conducted, 
using structured questionnaires, and BP and physiological parameters measure-
ments. Descriptive statistics were performed for all measures as appropriate. To 
assess differences among the vegan, semi-vegetarian, and meat-eater groups by 
demographic, BP and health behavior data, Chi-Square test and Fisher’s exact test 
for categorical variables, or analysis of variance tests and independent t-test for 
continuous variables were performed. The relationship between BP and dietary 
patterns was assessed using a multiple linear regression (MLR) model. All data 
were analyzed using SPSS 20.0 statistical analysis software. Results: Among the 
total participants, 65 (24.2%), 105 (39.0%), and 99 (36.8%) were the vegan, semi-
vegetarian, and meat-eater groups. Significant difference was found among three 
groups according to age, race, educational, employment, stress and waist-hip ratio. 
Based on BP, the systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
were significantly different among the three groups. When SBP and DBP were con-
sidered independently, waist-hip ratio was significantly different between the good 
and poor controls in both SBP and DBP. Therefore, BP was predicted as a function 
of the three groups considering for waist-hip ratio. The R2 for the MLR model was 
0.02, indicating that 2% of the variance in SBP and DBP were accounted for by the 
independent variables. The three groups were observed to be a significant predictor 
of SBP (β = 0.14, p= .02) and DBP (β = 0.15, p= .02). cOnclusiOns: The dietary pattern 
is a predictor for the SBP and DBP outcome in Taiwanese females.
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Objectives: A number of studies have examined the impacts of pay-for-perfor-
mance programs on quality of care, but little is known about long-term effects of 
these programs on the health care outcomes. This study aimed at examine the 
effects of the pay-for-performance program for type 2 diabetes patients on diabetes-
related complications under the National Health Insurance in Taiwan. MethOds: 
A longitudinal cohort study with 5-year follow-up was used to evaluate the effects 
of the pay-for-performance program on diabetes-related complications. Research 
materials came from claims files of the Longitudinal Health Insurance Database 
(LHID) 2005 released by the National Health Research Institute in Taiwan. Patients 
newly diagnosed as diabetes in 2004-2006 were included in the study. Patients joined 
the pay-for-performance program and received the comprehensive care over 12 
months during 2004 to 2010 were categorized as the case group. Patients never 
joined the pay-for-performance program during follow-up period were categorized 
as control group. Since patients who enrolled in the pay-for-performance program 
or not is not randomization, we applied the propensity score matching (PSM) to 
increase the comparatives between these two groups. The outcomes were the inci-
dences of cardiovascular diseases. Results: Patients in the case group experienced 
cardiovascular event significantly later than control group. The marginal hazard 
ratios of different propensity score method ranged from 0.60 to 0.63. Patients in the 
case group also had significant lower risks of heart failure, myocardial infarction 
and stroke between than patients in the control group. cOnclusiOns: The pay-
for-performance program may have reduced the incidence of cardiovascular events 
among patients newly diagnosed with diabetes who participated in the program 
for over 12 months.
PCV57
a retrosPeCtiVe, longituDinal stuDy to inVestigate the Change of 
lDl-C leVel anD PharmaCeutiCal interVention By using JaPanese 
health Care CheCkuP DataBase
Tomita C.1, Ii Y.1, Shima D.1, Yamamoto Y.2, Nagayasu S.2, Suga O.1, Fujimoto Y.1
1Pfizer Japan Inc, Tokyo, Japan, 2MinaCare co.ltd, Tokyo, Japan
Objectives: To investigate the LDL-c levels and pharmaceutical interventions in 
Japanese subjects under real life settings based on longitudinal data from a Japanese 
health care checkup database developed by MinaCare Co. Ltd. MethOds: Data 
of those subjects with annual health checkup from 2010 to 2012 were extracted 
from MinaCare database (cutoff November 2013). From these data, 11830 subjects 
with 3 years of parameter values (LDL-c, etc.) were used to assess their longitudi-
nal changes and the self-reported use of medications. The reliability of MinaCare 
database has been evaluated in a separate investigation to be presented at ISPOR 
19th Annual International Meeting. The final report of this investigation will be 
based on the latest of the periodically updated database at reporting. Results: At 
baseline (2010), 11.9% (1410/11830) of the subjects reported LDL-c≥ 160 mg/dL (tar-
get level for low risk hyperlipidemia population). Despite these high LDL-c values, 
95.4% (1345/1410) of these subjects answered “untreated by anti-hyperlipidemia 
drug” (including one non-respondent). Among these 1345 subjects, 1257(93.5%) 
answered “untreated” again in 2011; and among these “untreated”, the proportions 
of subjects with LDL-c< 140 (diagnositic level for hyperlipidemia), 160< LDL-c≤ 180 
and LDL-c≥ 180 in 2011 were 13.5%(n= 170), 32.9%(n= 413) and 22.9%(n= 228), respec-
tively. In contrast, among those who answered “treated” in 2011, the proportion 
with LDL-c< 140 was dramatically higher (69.8%, n= 60).Additionally, among those 
who answered “untreated” in 2011, the proportion answering “untreated” in 2012 
(i.e. “untreated” in 3-consecutive years) was 94.1% (n= 1183); among these subjects, 
the proportions of subjects with LDL-c< 140, 160< LDL-c≤ 180 and LDL-c≥ 180 in 2012 
were 16.5%(n= 195), 29.8%(n= 352) and 25.0%(n= 296), respectively. cOnclusiOns: 
Our investigation showed that > 90% of subjects self-reported no treatment with 
